| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |